PLD1 and Alzheimer disease: The PLD1 ablation and chronic inhibition using a well-tolerated PLD1-specific small molecule inhibitor prevent the progression of synaptic dysfunction during early stages in the 3xTg-AD mouse model (Bourne et al., 2019).